Skip to Content

Novonesis AS ADR NVZMY

Morningstar Rating
$55.03 +0.57 (1.05%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NVZMY is trading at a 5% premium.
Price
$54.45
Fair Value
$49.16
Uncertainty
Medium
1-Star Price
$78.22
5-Star Price
$38.48
Economic Moat
Nsgzy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NVZMY is a good fit for your portfolio.

Trading Information

Previous Close Price
$54.46
Day Range
$54.9755.49
52-Week Range
$38.7561.86
Bid/Ask
$54.94 / $55.58
Market Cap
$25.55 Bil
Volume/Avg
9,034 / 17,692

Key Statistics

Price/Earnings (Normalized)
30.07
Price/Sales
5.84
Dividend Yield (Trailing)
1.08%
Dividend Yield (Forward)
1.08%
Total Yield
1.09%

Company Profile

Novonesis AS formerly Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company is the world leader in industrial enzymes and microbial solutions, with a near-50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, working across more than 30 research and development and application centers and 23 manufacturing sites.
Sector
Basic Materials
Industry
Specialty Chemicals
Stock Style Box
Large Core
Total Number of Employees
6,756

Competitors

Valuation

Metric
NVZMY
DSFIR
IFF
Price/Earnings (Normalized)
30.0763.1135.89
Price/Book Value
7.291.191.46
Price/Sales
5.842.261.86
Price/Cash Flow
24.1922.9722.35
Price/Earnings
NVZMY
DSFIR
IFF

Financial Strength

Metric
NVZMY
DSFIR
IFF
Quick Ratio
0.761.200.74
Current Ratio
1.301.961.67
Interest Coverage
23.08−3.42−5.63
Quick Ratio
NVZMY
DSFIR
IFF

Profitability

Metric
NVZMY
DSFIR
IFF
Return on Assets (Normalized)
11.42%1.31%0.70%
Return on Equity (Normalized)
23.56%2.01%1.40%
Return on Invested Capital (Normalized)
19.08%1.93%1.90%
Return on Assets
NVZMY
DSFIR
IFF
See how this stock stacks up to its competitors with Morningstar Investor

Specialty Chemicals Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
LIN
Linde PLCXbtxxkdRhwpk$215.0 Bil
SHW
Sherwin-Williams CoRpktkdwnrKsxvq$78.8 Bil
ECL
Ecolab IncCndllcncpXbt$62.7 Bil
APD
Air Products & Chemicals IncBnfxjwmfzJvn$51.8 Bil
LYB
LyondellBasell Industries NV Class AWvxfspprKwhns$32.3 Bil
PPG
PPG Industries IncKdnhsfvZrddnw$31.8 Bil
DD
DuPont de Nemours IncSfsckzvMprjn$30.7 Bil
IFF
International Flavors & Fragrances IncSbtvssrdnPqsv$21.3 Bil
ALB
Albemarle CorpMbnzpqkfGvnwwf$13.4 Bil
SQM
Sociedad Quimica Y Minera De Chile SA ADRKytwqvrtdBzbwlbd$13.0 Bil

Sponsor Center